FUJIFILM Diosynth Biotechnologies announces changes impacting 30+ local workers
COLLEGE STATION, Texas (KBTX) – FUJIFILM Diosynth Biotechnologies announced Wednesday a restructure to its workforce impacting more than 200 employees at multiple locations including its facility in College Station.
“FUJIFILM Diosynth Biotechnologies today announced the decision to globally restructure its Small Scale Business Unit, which may result in up to 240 employees leaving the company. This impacts employees at its Teesside sites in the UK, and sites in College Station, Texas, Raleigh, North Carolina, and Watertown, Massachusetts, in the US,” the company shared in a news release.
Several sources tell KBTX’s Rusty Surette that 33 workers are being impacted by the restructuring at the facility in College Station
The company shared in its statement, “Alongside measures taken to manage its operational and financial performance, FUJIFILM Diosynth Biotechnologies’ Small Scale Business Unit has been directly impacted by the short-term challenge of reduced venture capital investment in early-stage research projects, particularly in the cell and gene therapies market.”
In 2020, the local facility made national news after it began mass production of a COVID-19 vaccine as part of a program launched under the federal government’s “Operation Warp Speed”.
In 2022, the company broke ground on a $300-million expansion project at its College Station campus, creating the largest single-use CDMO production campus in North America. As part of the ceremony, the City of College Station also renamed the adjacent roadway Fujifilm Way.
